Shares of OpGen, Inc. (NASDAQ:OPGN – Get Free Report) passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $1.02 and traded as high as $1.25. OpGen shares last traded at $1.25, with a volume of 962 shares changing hands.
Analyst Upgrades and Downgrades
Separately, StockNews.com began coverage on shares of OpGen in a report on Friday. They issued a “sell” rating on the stock.
Check Out Our Latest Stock Report on OPGN
OpGen Price Performance
About OpGen
OpGen, Inc, a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits.
Featured Stories
- Five stocks we like better than OpGen
- Growth Stocks: What They Are, What They Are Not
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- DuPont’s Electronics Spinoff: The Start of Something Big
- Retail Stocks Investing, Explained
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.
